Double antibiotic attack: could a Two-Drug combo beat severe infections faster?
NCT ID NCT07063095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a second antibiotic (fosfomycin) to the standard antibiotic (ceftazidime) helps people with severe gram-negative infections recover faster. About 100 hospitalized adults will be randomly assigned to get either the combo or the standard drug plus a placebo. Researchers will measure how quickly signs of infection improve and check for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM NEGATIVE INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brain waves predict thinking problems after sepsis?
- Blood gas clues could reveal hidden danger in sepsis patients
- Tiny molecules may hold key to septic shock immune failure
- Blood oxygen test may guide fluid therapy in sepsis
- Can a rapid test help doctors pick the right antibiotic faster?
- Could a second steroid boost survival in septic shock? tiny trial paves way